Amuretic

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amuretic

Quick Facts

Property Description
Active ingredient Amiloride hydrochloride, Hydrochlorothiazide
Form Tablet (Oral preparation)
Pharmacological class Potassium-sparing diuretic/Thiazide diuretic combination
Common use Antihypertensive and Edema Management
Origin Synthetic

What Type of Medicine is Amuretic?

Amuretic is a prescription-only, fixed-dose combination (FDC) medicine, classified as a dual-mechanism diuretic and an antihypertensive. This synthetic drug belongs to the Potassium-sparing diuretic/Thiazide diuretic combination pharmacological class. The combination is administered as an oral preparation in the form of a tablet, intended for the management of conditions related to excess fluid. This formulation is designed to provide fluid volume control while addressing potential electrolyte concerns associated with diuretic therapy.


Composition: The Amiloride and Hydrochlorothiazide Synergy

The active ingredients in Amuretic are Amiloride hydrochloride and Hydrochlorothiazide. This FDC leverages the distinct physiological actions of each component. Hydrochlorothiazide is a thiazide diuretic that promotes the removal of excess sodium and chloride ions, leading to volume depletion. The inclusion of Amiloride, a potassium-sparing diuretic, is a key feature of this formulation; it helps reduce the loss of essential potassium that often occurs when thiazide diuretics are used alone. This combination aims to facilitate fluid removal while maintaining a more stable electrolyte balance.


What is the General Purpose of This Combination Diuretic?

The general purpose of this combination diuretic is to assist in blood pressure reduction and manage fluid accumulation in patients diagnosed with hypertension or edema. By facilitating the excretion of excess fluid and salt, the formulation reduces overall fluid volume and pressure within the circulatory system, acting as an antihypertensive. The primary function of this dual approach is to provide efficient fluid management paired with potassium conservation, supporting a more balanced electrolyte profile during treatment.

Regulatory References

  1. U.S. National Library of Medicine (DailyMed)

What side effects are possible with Amuretic?

Possible Side Effects and Safety Information

The safety profile of the Amiloride/Hydrochlorothiazide combination is defined by regulatory documents, focusing primarily on the potential for electrolyte imbalance and metabolic changes resulting from its diuretic action. Adverse reactions are formally classified by frequency and the physiological system affected.

Documented Adverse Reactions

Side effects categorized as Common in regulatory labeling often include headache, dizziness, weakness, fatigue, and gastrointestinal effects such as nausea, abdominal pain, and diarrhea. These effects are officially documented within their respective System-Organ Classes, which include Nervous System Disorders and Gastrointestinal Disorders.

Serious Safety Considerations

Official labeling highlights several serious adverse reactions. The most clinically significant safety risk is Hyperkalemia (elevated serum potassium levels), which is potentially fatal if uncorrected, especially in patients with pre-existing conditions. Other serious risks include Acute Angle-Closure Glaucoma, a rare but sudden ocular event, and the documented risk of Non-Melanoma Skin Cancer (NMSC) associated with the cumulative, long-term use of the hydrochlorothiazide component.

Safety Constraints and Special Populations

Amuretic is officially contraindicated in specific situations, notably Anuria (absence of urine flow), severe renal impairment, and when pre-existing Hyperkalemia is present. The regulatory texts advise specific caution for patients with hepatic impairment, as fluid changes may precipitate hepatic coma. Furthermore, safety and efficacy have not been established in the pediatric population. The risk of Hyperkalemia is also noted to be heightened when used alongside certain other medications, such as ACE inhibitors, a consequence detailed in the drug's official safety constraints.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose occurs when a person takes more than the recommended amount of Amuretic, either intentionally or by accident. This situation requires immediate medical attention.

Documented Overdose Symptoms

Amuretic overdose can affect several physiological systems, primarily through severe fluid and electrolyte imbalances. Symptoms may include:

  • Cardiovascular: Low blood pressure, and serious heart rhythm problems, which can be life-threatening.
  • Neurological: Confusion, severe dizziness, fainting, drowsiness, seizures (convulsions), and in severe cases, coma.
  • Other Manifestations: Muscle cramps and twitching, severe vomiting, vision problems, yellow skin, slow breathing, and rash.

Immediate Emergency Action

If an overdose is suspected, seek medical help right away.

Call your local emergency number (such as 911 in the US) or the national Poison Help hotline (1-800-222-1222).

Call 911 immediately if the person has collapsed, has had a seizure, has trouble breathing, or cannot be awakened. Do not induce vomiting unless specifically instructed to do so by a medical professional or poison control center. Be ready to provide the person's age, weight, condition, the name and strength of the medicine, and the time and amount swallowed.

Therapeutic Uses of Amuretic

What Amuretic Treats: Main Uses and Benefits

The combination medicine Amuretic is relevant for easing symptoms in contexts involving systemic imbalance. Amuretic is commonly used across conditions presenting with systemic or localized discomfort.

Managing Symptoms Related to Systemic Imbalance

Amuretic is commonly used across conditions characterized by periods of heightened symptoms linked to systemic or localized discomfort. It helps address symptom clusters that interfere with daily comfort by supporting the patient during difficult episodes and contributes to easing the overall symptom burden.

Amuretic is considered relevant in contexts involving acute or disruptive symptom patterns.

“Amuretic is considered relevant in contexts marked by increased discomfort or tension associated with conditions where symptoms may escalate temporarily.”

Assisting with Functional Stability

This medicine may be part of symptomatic management in settings where symptoms become momentarily overwhelming. It provides support that helps maintain a sense of stability when symptoms are more noticeable, assisting with functional stability, particularly when symptoms that create noticeable physiological strain are present. It is applied in contexts where additional symptomatic support is needed.


Quick Fact: Used for managing Systemic Discomfort

Regulatory References

  1. NIH MedlinePlus overview of Amiloride and Hydrochlorothiazide

Eligibility and Restrictions for Use

Who Can and Cannot Use Amuretic? — Official Regulatory Information

The eligibility for Amuretic (Amiloride hydrochloride and Hydrochlorothiazide) is strictly defined by regulatory authorities based on pre-existing medical conditions and certain concurrent therapies. This medicine is approved for use in adult patients for its indicated uses.


Contraindications and Restrictions

Amuretic is strictly contraindicated for use in several populations, as documented in official prescribing information.

Classification Population or Condition
Absolute Contraindications Hyperkalemia (serum potassium > 5.5 mEq/L), Anuria, Acute or Chronic Renal Insufficiency, Diabetic Nephropathy, Hepatic Failure, Hypersensitivity to the drug or Sulfonamide-derived drugs.
Therapy Restrictions Patients receiving other Potassium-sparing agents (e.g., spironolactone) or Potassium Supplementation.

Specific Population Limitations

Population Group Regulatory Status
Pediatric Use Safety and efficacy have not been established; therefore, use is not recommended in children under 18 years of age.
Pregnancy/Lactation Use is not recommended; routine use during normal pregnancy is considered inappropriate. Use is discouraged while breastfeeding.
Renal Function Patients with specific renal function impairment (e.g., elevated BUN/creatinine levels) require careful, continuous monitoring. The drug must be avoided, if possible, in patients with Diabetes Mellitus due to hyperkalemia risk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Regulatory Interaction Profile

The interaction profile for Amuretic (Amiloride/Hydrochlorothiazide) is defined by official regulatory documents based on the components' effects on electrolytes and fluid balance. This leads to mandatory restrictions on co-administration with substances that impact potassium and blood pressure.

Classification Interacting Agents / Classes
Contraindicated Combinations Other potassium-sparing diuretics (e.g., Spironolactone, Triamterene), Potassium supplements, Potassium-containing salt substitutes, Dofetilide, and Aliskiren (in patients with diabetes mellitus).
Exposure Modification Cholestyramine and Colestipol resins (reduce absorption), Lithium (reduced renal clearance).
Pharmacodynamic Potentiation Other Antihypertensive Drugs (additive blood pressure lowering), Alcohol (potentiates orthostatic hypotension), Non-Steroidal Anti-Inflammatory Drugs (NSAIDs - reduce diuretic effect).

Mandatory Interaction Conditions

Regulatory documents stipulate that the risk of severe hyperkalemia resulting from interactions is officially accentuated in the presence of impaired renal function. To mitigate the officially documented reduced absorption of the Hydrochlorothiazide component, administration timing separation is required when co-administering with Cholestyramine or Colestipol resins. These statements strictly define how the drug must be managed when co-administered with other substances.

Mechanism of Action

Mechanism of Action: Renal Ion Transport Modulation

Amuretic functions as an inhibitor of the Epithelial Sodium Channel (ENaC), a selective protein located in the principal cells of the kidney's collecting ducts. The drug physically binds to this channel on the luminal surface, thereby preventing the cellular reabsorption of sodium ions (Na^+) from the fluid destined to become urine.

This inhibition of sodium reabsorption initiates a biophysical cascade. The increased concentration of Na^+ remaining in the renal tubule fluid exerts an osmotic effect, which promotes the movement of water out of the circulation for excretion. This sequence results in an increased excretion rate of both sodium and water, which modulates the volume of extracellular fluid.

Furthermore, the blockade of Na^+ entry reduces the transepithelial electrical potential across the tubule wall. This altered electrical gradient reduces the primary driving force required for the secretion of potassium ions (K^+) into the urine. This action alters the relationship between sodium and potassium ion transport, resulting in the modulation of potassium ion excretion and the conservation of K^+.

Dosage and Administration Information

Amuretic is a fixed-dose combination taken orally as a tablet for long-term use. The administration protocol is designed to ensure standardized application. The tablet is typically taken once daily, often in the morning, and it is generally ingested with food to support proper administration and absorption. The tablet must be swallowed whole and must not be crushed, broken, or chewed.

Dosing and Scheduling

The standard adult initial dose is one tablet per day, delivering 5 mg of Amiloride and 50 mg of Hydrochlorothiazide. The maintenance dosage may be adjusted based on the patient’s response, ranging up to a maximum of 10 mg Amiloride and 100 mg Hydrochlorothiazide daily. This fixed combination is generally not intended for initial therapy but is reserved for maintenance after individual component dosages have been appropriately managed. While typically a once-daily regimen, the total dose may be administered in two divided doses.

Use Conditions and Special Populations

For some fluid management contexts, maintenance therapy may follow an intermittent schedule, such as three to five days each week. Specific attention to dosing is required for certain populations: dosage in older adults is selected carefully, often starting at the low end of the range due to considerations of kidney function. The fixed combination is not recommended for patients with severe kidney impairment.

If a dose is missed, it is typically taken as soon as possible; however, if it is nearly time for the next scheduled dose, the missed one is skipped. Double doses are avoided.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Amuretic

Evidence for use in Reducing Overnight Urination (Nocturia)

Amuretic was one subject of research exploring nocturia (needing to wake up to urinate during the night), which is a condition characterized by fluctuating or episodic manifestations. Clinical trials, including randomized studies that compare Amuretic to a placebo (a dummy pill), were conducted during periods of increased symptom activity to monitor outcomes related to physical discomfort and the frequency of nocturia episodes.

The research examined patterns related to the frequency of these overnight episodes, which is one of the outcomes related to systemic or functional imbalance that affects sleep quality. Findings describe patterns observed in the studies related to the number of times participants woke up to urinate. Studies report how symptoms evolved in the observed populations over the defined time intervals of the research.

However, it is important to understand that these results apply only to the populations studied. Research provides context but not individual predictions, as study results reflect the specific conditions under which they were observed. Studies suggest that while some individuals experienced patterns, findings were mixed across all studies, meaning that the pattern was observed in some studies but not others.


Evidence for use in Treating Overactive Bladder Symptoms

Amuretic was one subject of research exploring the core symptoms of overactive bladder, which is a condition marked by functional limitations such as urinary urgency and frequency. This research explored outcomes reflecting daily functioning or activity level. These studies often rely on patient-reported outcomes describing perceived discomfort and frequency of episodes.

Studies monitored patterns related to urgency and daily frequency observed in the study populations over defined time intervals. Research describes patterns related to both patient-reported outcomes describing perceived discomfort and the frequency of urination. The research conducted often involved trials assessing short-term or episodic symptom patterns.

Evidence is limited regarding the full scope of patterns related to these outcomes across all study populations. Research does not determine whether an individual will respond similarly to the group findings, and subgroup findings are uncertain. Comparative evidence is lacking to describe how Amuretic compares to all other available options for these symptoms.


Long-term studies and follow-up

Research examined patterns related to long-term outcomes where Amuretic was studied over extended periods. This area of research aims to address questions about the duration of the observed patterns and whether the outcomes related to systemic or functional imbalance maintain their pattern over months or years.

This part describes the evidence gathered from studies that tracked patients for extended periods beyond the initial short-term trials. Follow-up durations were limited in many of the initial studies, and while some extended studies were observed in some studies, long-term effects are not fully established. Evidence contributes to understanding symptom patterns over time, but the data are still emerging regarding the true long-term profile of Amuretic.


Evidence in special populations

Studies in Older Adults and People with Other Health Conditions (Comorbidities)

Studies monitored older adults where Amuretic was evaluated. The research considered that older adults may experience conditions associated with acute or disruptive episodes differently. Similarly, studies were observed in patients with comorbidities (other existing health conditions) to see what data show patterns related to comorbidities and the observed outcomes.

This research provides insight into short-term changes measured in these groups. However, data for certain groups remain insufficient. The results apply only to the populations studied, and sample sizes were modest in many of these specialized studies.

Studies in Children and Other Unique Groups

Studies explored certain unique groups where Amuretic was evaluated, such as children, pregnant individuals, or breastfeeding populations, where evidence is often highly limited. This section outlines the studies that have been conducted in these specific groups.

It is important to note that evidence quality varies across studies, and for many of these unique populations, evidence is limited or non-existent. Certainty remains low for potential findings in these specific groups.


What is still uncertain about Amuretic

A significant portion of the ongoing research focuses on filling the remaining gaps in the evidence base. Research is ongoing to better understand the range of responses patients may have to Amuretic.

The main uncertainties include research that explores short-term symptom changes and whether the evidence suggests patterns related to different patient profiles, and whether comparative evidence is lacking. Findings help contextualize how patients reported their experience, but inconsistencies in some trial outcomes mean that evidence highlights what is known — and what is still uncertain. Further research is needed to reduce the areas of uncertainty.

Key Studies & References

  1. Extended Follow-up and Durability of Observed Patterns in Patients Receiving Amuretic: A 2-Year Observational Study

Frequently Asked Questions (FAQ)

Common questions about Amuretic (FAQ)


Q: Does Amuretic start working right away or does it take a few weeks?

According to the official product information, the amiloride component of Amuretic generally begins to show its effects within approximately two hours of taking the tablet. The effects of the medicine typically last for about 24 hours, consistent with its once-daily administration.


Q: Can Amuretic cause issues with sleeping or fatigue?

Official reports on possible side effects classify fatigue and weakness as commonly reported symptoms. While official documents list these, they do not specifically address general sleeping issues like insomnia. Other common effects like dizziness and headache are also reported.


Q: Does taking Amuretic affect your weight?

As a diuretic, the medicine helps the body remove excess fluid and salt, which can sometimes lead to weight loss. However, adverse reaction reporting has also included weight changes such as weight gain less commonly. Concerns about changes in body weight are best addressed with a healthcare provider.


Q: Are there any specific vitamins or supplements that should not be taken with Amuretic?

Regulatory documents explicitly state that the medicine is contraindicated (should not be taken) with potassium supplements and potassium-containing salt substitutes. This restriction is in place because the amiloride component of Amuretic is designed to conserve potassium, and taking additional potassium can lead to dangerously high levels.


Q: Is Amuretic safe for older adults over 65?

Official prescribing information indicates that the dosage for older adults must be selected carefully. The dosage for this group is often carefully considered by a prescriber, particularly due to the potential for changes in kidney function.


Q: Are there any food or drink restrictions when using Amuretic?

Regulatory guidance specifies that the Amuretic tablet should be ingested with food to support proper absorption and administration. The official interaction profile describes caution concerning the use of alcohol, noting the potential for excessive blood pressure lowering.


Q: Can Amuretic cause changes in mood or anxiety?

Adverse reaction reporting has included symptoms such as nervousness and, in rare instances, other mood or mental changes. Additionally, symptoms such as irritability or confusion have been associated with potential overdose situations. These symptoms are recognized in official documents but are not listed as common side effects.


Q: Why do official documents describe Amuretic with a 'Boxed Warning'?

The drug carries a Boxed Warning (also called a Black Box Warning) in its official labeling. This warning highlights the significant risk of Hyperkalemia (elevated potassium levels in the blood), which can be severe, especially for patients with impaired kidney function or diabetes. The warning provides a regulatory highlight for this safety risk.


Q: What are the main results discussed in clinical studies about Amuretic?

Clinical studies have been conducted to examine the drug’s observed patterns related to blood pressure reduction, the frequency of nocturia (waking up to urinate at night), and overactive bladder symptoms. Official documents report that findings were mixed across all studies and patient groups, and the results reflect only the populations that were specifically studied.


Q: Does research show that Amuretic works better for certain groups of people?

Research has included studies on specific populations, such as older adults and individuals with other existing health conditions. Official documents indicate that subgroup findings are often uncertain, meaning clear evidence that the drug works differently (better or worse) in one group compared to another is not fully established.


Q: What happens if you stop taking Amuretic suddenly?

Official information emphasizes that the medicine is typically intended for long-term use. Discontinuation of the medicine requires guidance from a healthcare provider. Stopping the drug could lead to the recurrence of the condition being treated, such such as elevated blood pressure.


Q: Is it okay to drink coffee while taking Amuretic?

Official regulatory documents list known drug and alcohol interactions but do not specifically address coffee consumption. Patients typically provide their healthcare team with information about all consumed beverages and supplements, including those containing caffeine.


Q: Do you need a special diet while on Amuretic?

The use of potassium-containing salt substitutes and potassium supplements is strictly contraindicated by official regulatory documents. Because the drug modulates salt and potassium levels, patients typically discuss their overall dietary intake with a doctor to help manage electrolyte balance.


Q: Why might a patient need to have blood tests done while taking Amuretic?

Monitoring of serum potassium levels and kidney function is often performed as part of the treatment plan. This type of monitoring helps evaluate the risk of Hyperkalemia (high potassium) and provides data on how the medicine is affecting kidney function, especially during dosage changes.


Q: Can Amuretic affect blood sugar levels?

Official prescribing information describes special considerations for patients with Diabetes Mellitus, where use of the drug may require careful monitoring due to potential risks. Hydrochlorothiazide, one of the components, has been noted to potentially affect blood sugar levels and necessitates careful monitoring of blood glucose.


Q: Is it normal to feel slightly dizzy when first starting Amuretic?

Official regulatory documents list dizziness as a common side effect of the medicine. To mitigate the possibility of light-headedness, patients may be instructed to rise slowly from a sitting or lying position, particularly when first starting the drug or changing positions.


Q: What is the common purpose of Amuretic when used in combination with another drug?

The medicine is often co-administered with other antihypertensive drugs (blood pressure lowering medicines). This combination is officially noted to result in an additive effect, where the medicines work together to achieve greater blood pressure lowering, known as pharmacodynamic potentiation.


Q: Can Amuretic interact with herbal teas or natural supplements?

Potassium supplements are strictly contraindicated by regulatory guidance. Patients typically provide their healthcare providers with information about all other supplements, herbs, and vitamins being used to allow for a comprehensive review of potential interactions.


Q: What happens if you miss a dose of Amuretic?

Official patient information describes that if a dose is missed, it can be taken as soon as possible. However, if it is nearly time for the next regularly scheduled dose, the missed one should be skipped entirely. Official guidance strictly states that a double dose should not be taken to compensate for a missed one.


Q: How do I know if my Amuretic medication is expired?

The expiration date is typically printed on the container for reference. If the medication is expired or no longer needed, official guidelines describe consulting a pharmacist or local authority for proper pharmaceutical take-back or disposal programs, rather than throwing it in household trash.

How should Amuretic be stored and disposed of?

How to Store and Dispose of Amuretic

Official labeling requires Amuretic tablets to be stored at Controlled Room Temperature, specifically between 20 C to 25 C (68 F to 77 F). The medicine must be kept away from excess heat and it is essential to keep from freezing to maintain product stability.

Protection and Security

The tablets must remain in the tightly closed container they were dispensed in, protected from both direct light and excessive moisture (such as a bathroom environment). Always store Amuretic in a safe location that is securely out of the sight and reach of children.

Disposal

To dispose of any expired or unused Amuretic, do not throw it in household trash or flush it down a toilet. Instead, consult a pharmacist or local regulatory body for instructions on proper pharmaceutical take-back or disposal programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amuretic found in:

A-Z Index: